Parasite | Eso | Sto | Cancer | ESD
[ºñ¸¸. Obesity] - ðû
1. Introduction
2. ºñ¸¸ ¼ö¼ú
5. Symposiums
6. References
ºñ¸¸Àº Áúº´ÀÔ´Ï´Ù. À½½ÄÀ» ÁÙÀÌ°í ¿îµ¿À» ´Ã·Á Ä¡·áÇÏ´Â º´ÀÔ´Ï´Ù. ¾àÀ̳ª ¼ö¼úÀ̳ª ³»½Ã°æ ½Ã¼úÀº ±×¾ß¸»·Î ¸¶Áö¸·¿¡ ÇØ º¼ ¼ö ÀÖ´Â À§ÇèÇÑ ¹æ¹ýÀÔ´Ï´Ù. ½±°í ÁÁÀº ÀÏÀº ¾ø½À´Ï´Ù.
ºñ¸¸Àº °³ÀÎÀÇ ¹®Á¦¸¸Àº ¾Æ´Õ´Ï´Ù. (1) ³ª»Û À½½ÄÀ» ¸Ô±â ½¬¿î ȯ°æ, (2) ¿îµ¿ÇÒ ½Ã°£°ú Àå¼Ò°¡ ºÎÁ·ÇÑ ºñÀΰ£Àû ȯ°æÀÌ ¹®Á¦ÀÇ ÇÙ½ÉÀÔ´Ï´Ù. »çȸÀûÀÎ ¹®Á¦ÀÔ´Ï´Ù. Ȥ½Ã ¿ì¸®µµ ¾Æħ°ú Àú³áÀÌ ¾ø´Â °ÇÑ ±Ù¹« °µµ¸¦ ´ç¿¬½Ã ¿©±â°í ÀÖ´Â °Í ¾Æ´Ò±î¿ä?
¼¼ °¡Áö ¼ö¼ú ¹æ¹ýÀÌ ÀÖ½À¤¤´Ù. °ú°Å¿¡´Â bypass ¼ö¼úÀÌ ¸¹ÀÌ ½ÃÇàµÇ¾úÁö¸¸ ÃÖ±Ù¿¡´Â sleeve gastrectomy°¡ ´ë¼¼ÀÔ´Ï´Ù.
³»½Ã°æ Àǻ絵 ºñ¸¸ ¼ö¼ú ÈÄ ³»½Ã°æ ¼Ò°ß¿¡ Àͼ÷ÇØÁú ÇÊ¿ä°¡ ÀÖ½À´Ï´Ù.
Gastric bypass ¼ö¼úÀ» ¹ÞÀº 30´ë Áß¹Ý ¿©¼ºÀÇ ÀÛÀº remnant stomach. ºñ¸¸ ¼ö¼ú Áß gastric bypass´Â À§¸¦ ¾ÆÁÖ ÀÛ°Ô ¸¸µé¾î ¼ÒÀå°ú ¿¬°áÇÏ´Â ¹æ¹ýÀÔ´Ï´Ù. ±×·±µ¥ ³ª¸ÓÁö À§¸¦ Á¦°ÅÇÏ´Â °ÍÀÌ ¾Æ´Ï°í ¸ö ¼Ó¿¡ ±×´ë·Î ³²±é´Ï´Ù. ³»½Ã°æÀ¸·Î´Â °üÂûÇÒ ¼ö ¾ø½À´Ï´Ù. µû¶ó¼ À§¾ÏÀÌ ¸¹ÀÌ ¹ß»ýÇÏ´Â ¿ì¸®³ª¶ó¿¡¼´Â À§¾Ï °ËÁøÀ» ÇÒ ¼ö ¾ø´Â bypass ¼ö¼úÀº À§ÇèÇÑ ¹æ¹ýÀÔ´Ï´Ù.
À§ band ¼ö¼ú - ¾Öµ¶ÀÚ Áõ·Ê ÆíÁö 54
1) ºñ¸¸°ú ´ë»ç¼º ÁúȯÀÇ ³»½Ã°æ Ä¡·á - ¿¬¼¼´ëÇб³ ½Å¼º°ü (2015³â ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¼ÒȱâÇÐ ¿¬¼ö°ÁÂ)
ºñ¸¸Àº º¸±â ½ÈÀº »óÅ°¡ ¾Æ´Ï¶ó Áúº´ÀÔ´Ï´Ù. ¼¾çÀο¡ ºñÇÏ¿© µ¿¾çÀο¡¼´Â µ¿ÀÏ BMI¿¡¼ üÁö¹æ·üÀÌ ³ô°í ºñ¸¸°ü·Ã Áúȯµµ ¸¹±â ¶§¹®¿¡ ¼¾çº¸´Ù ´Ù¼Ò tightÇÑ Áø´Ü±âÁØÀ» Àû¿ëÇØ¾ß ÇÕ´Ï´Ù.
ºñ¸¸ °ü·ÃÇÏ¿© À§¸¦ ¼ö¼úÇϸé üÁß°¨¼ÒÈ¿°ú¸¸ ÀÖÁö¸¸ ¼ÒÀåÀ» ¼ö¼úÇϸé üÁßÀÌ ºüÁú»Ó¸¸ ¾Æ´Ï¶ó ´ç´¢°ü·Ã ¿©·¯ ÁöÇ¥°¡ °³¼±µË´Ï´Ù. ¾ÆÁ÷±îÁö Àß ¾Ë·ÁÁöÁö ¾ÊÀº ±âÁØÀÌ ÀÖÀ» °ÍÀÔ´Ï´Ù. üÁß°¨¼Ò ½Ã¼ú ÈÄ ´ç´¢°¡ ÁÁ¾ÆÁö´Â ±âÀü Áß Çϳª·Î incretin À̶ó´Â È£¸£¸óÀÇ ¿ªÇÒÀÌ ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. ¿¹»óÄ¡ ¸øÇÑ ´Ù¸¥ ±âÀüµéµµ ¿¬±¸µÇ°í ÀÖ½À´Ï´Ù.
1) À§¿¡ ½Ã¼úÇÏ´Â ¹æ¹ý
(1) Apollo overstich¸¦ ÀÌ¿ëÇÑ sleeve gastrectomy
(2) Incisionless operating plateform
(3) Aspiration therapy: PEG¿Í ºñ½ÁÇÑ ¿ø¸®·Î À½½ÄÀ» ¸Ô°í PEG tube¸¦ ÅëÇØ À½½ÄÀ» »Ì¾Æ³»´Â ¹æ¹ý.
2) ¼ÒÀå¿¡ ½Ã¼úÇÏ´Â ¹æ¹ý
(1) Duodenal sleeve
(2) Duodenal mucosal resurfacing
1) °íµµºñ¸¸ ¼ö¼ú ÈÄ ¹ß»ýÇÑ short bowel syndrome (2016³â 6¿ù 10ÀÏ SMC Áý´ãȸ)
ºñ¸¸ ¼ö¼ú ÈÄ ¹ß»ýÇÑ ºÎÁ¾À¸·Î ³»¿øÇÑ 30´ë ¿Ü±¹ÀÎ. °íµµºñ¸¸À¸·Î µÎ¹øÀÇ gastric bypass surgery ÈÄ ³»¿ø 3°³¿ùÀüºÎÅÍ ¹ß»ýÇÑ both lower leg edema, bruise ·Î 2Â÷º´¿ø ÀÔ¿ø Áß r/o protein losing enteropathy ·Î Àü¿ø. ÀÌ È¯ÀÚ´Â protein losing enteropathy´Â ¾Æ´Ï¾ú°í common channel ±æÀÌ°¡ ª¾ÆÁ® ¹ß»ýÇÑ short bowel syndromeÀ̾ú½À´Ï´Ù.
¥á1-Antitrypsin clearance °Ë»ç °á°ú´Â ¾Æ·¡¿Í °°ÀÌ Á¤»óÀ̾ú½À´Ï´Ù.
- ¥á1-Antitrypsin, serum : 95.3 mg/dL (ref. 90-200)
- ¥á1-Antitrypsin, feces : 8.5 mg/dL (ref. 0-54)
- ¥á1-Antitrypsin plasma clearance : 0.18 mL/day (ref. 27 mL/dayÀÌÇÏ)
°ø½Ä: Alpha 1-AT plasma clearance = ((stool volume) x (stool alpha 1-AT)) / (serum alpha-1 AT), Alpha-1-antitrypsin (A1A) is resistant to degradation by digestive enzymes and is, therefore, used as an endogenous marker for the presence of blood proteins in the intestinal tract. A1A clearance is reliable for measuring protein loss distal to the pylorus.
Albumin replacement, ¿µ¾ç °ø±Þ (TPN, high protein diet, protein powder, IV iron, vitamin K, vitamin B12 replacement) µî Ä¡·á ÈÄ Ã¼Áßµµ °¨¼ÒÇÏ°í ¿Â°® Áõ»óµµ È£ÀüµÇ¾î µÇÀÇ·ÚÇÏ¿´½À´Ï´Ù.
2) ºñ¸¸ ³»½Ã°æÄ¡·á ÈÄ ¹ß»ýÇÑ À§±Ë¾ç õ°ø. °í·Á´ëÇб³ ¾È¾Ïº´¿ø À¯Àΰæ (2016³â 4¿ù 29ÀÏ ³»½Ã°æÇÐȸ Áý´ãȸ)
7ÁÖ Àü ´ÙÀ̾îÆ®¸¦ ¸ñÀûÀ¸·Î À§³»Ç³¼±»ðÀÔ¼ú ÈÄ º¹ÅëÀ¸·Î ³»¿øÇÑ ¿©¼ºÀ̾ú½À´Ï´Ù. ½Äµµ ÀüÁ¤ºÎ¿¡ balloonÀÌ ÀÖ¾ú°í Àüº® õ°ø°ú peumoperitoneumÀ¸·Î ¼ö¼úÀ» ÇÏ¿´½À´Ï´Ù.
¼ö¼ú ½Ã õ°øÀÇ ±¸¸ÛÀº À۾Ƽ balloonÀº ³²°ÜµÎ¾ú°í ¼ö¼ú ¸î ÀÏ ÈÄ ³»½Ã°æÀ¸·Î balloonÀ» Á¦°ÅÇÏ¿´½À´Ï´Ù. dz¼± ½Ã¼ú ÈÄ PPI º¹¿ëÀ» ÀÚÀÇ·Î Áß´ÜÇÑ °ÍÀÌ Ãµ°ø ¹ß»ýÀÇ Áß¿ä ¿øÀÎÀ¸·Î ³íÀǵǾú½À´Ï´Ù.
Àú´Â "CT »çÁøÀ» º¸´Ï ±×¸® ½ÉÇÑ ºñ¸¸Àº ¾Æ´Ï´øµ¥ ³»½Ã°æÄ¡·áÀÇ ÀûÀÀÁõÀ̾ú´ø °Ô ¸Â½À´Ï±î?"¶ó°í Áú¹®À» ÇÏ¿´½À´Ï´Ù. ºñ¸¸ÀÌ Áúº´ÀÎ °ÍÀº ¸Â½À´Ï´Ù. ±×·¯³ª ºñ¸¸¿¡ ´ëÇÑ ¼ö¼úÀ̳ª ³»½Ã°æÄ¡·á´Â ¾ÆÁÖ ½ÉÇÑ ºñ¸¸ ȯÀÚ¿¡¼¸¸ ½ÃÇàµÇ¾î¾ß ÇÕ´Ï´Ù. ´Ü¼øÇÑ ¹Ì¿ë ¸ñÀûÀÇ ºñ¸¸ ¼ö¼ú°ú ³»½Ã°æÄ¡·á´Â ½ÅÇØö »ç¸Á »ç°í¿Í °°Àº ¶Ç ´Ù¸¥ ºñ±ØÀ» °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ºñ¸¸Ä¡·á ³²¹ßÇÏÁö ¸¿½Ã´Ù.
3) Asyptomatic band erosion (Yun GY. Clin Endosc 2016)
Endoscopic finding in the fundus area during routine gastroduodenoscopy. (A) Three years ago, routine gastroduodenoscopy shows an intact gastric mucosa. (B) One year ago, routine gastroduodenoscopy shows an intact gastric mucosa. (C) Recently, routine gastroduodenoscopy shows that the gastric band had eroded into the stomach with gastric ulcer perforation.
Abdominal and pelvic computed tomography for a routine health-check up in 2015. (A) Axial view, the gastric band partially eroded into the gastric lumen. The arrow shows that the gastric band caused gastric perforation. (B) Sagittal view, the eroded band is shown in the gastric lumen with gastric perforation.
4) ÀÚÇسª ÀÚ»ì
¼ö¼ú ½Ã¼ú ÀüÈÄ mental health¿¡ ´ëÇÑ »ó´ã°ú ÁÖÀÇ°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÚÇسª ÀÚ»ìÀÌ ³ô¾ÆÁø´Ù´Â ÀÚ·á°¡ ¸¹½À´Ï´Ù.
1) 2016-7-12 ³»½Ã°æÇÐȸ Áý´ãȸ Development of novel intragastric balloon: porcine model in vivo study (°í·Á´ëÇб³ ÀÌ»ó¿±)
"±âÁ¸ intragastric balloon (end ball)Àº ³»½Ã°æ ·»Áî ¾Õ¿¡ delivery systemÀÌ À§Ä¡ÇÏ¿© ½Ã¼ú °úÁ¤¿¡¼ ½Ã¾ßÈ®º¸°¡ ¾î·Á¿î ´ÜÁ¡ÀÌ ÀÖ¾ú´Ù. New intragastric balloonÀÇ delivery systemÀº ³»½Ã°æ ÀÏüÇü ½Ã½ºÅÛÀ¸·Î ½Ã¼ú°úÁ¤¿¡¼ ½Ã¾ßÈ®º¸°¡ ¿ëÀÌÇÏ¿© ±âÁØ ¹æ½Ä¿¡ ºñÇÏ¿© ½Ã¼ú½Ã°£ ´ÜÃàÀÌ ±â´ëµÈ´Ù."
Weight loss through each month of Orbera balloon therapy. Results from studies reporting weight loss through each month of Orbera balloon therapy were tabulated. Peker et al included 31 patients with an average starting body mass index of 41.8 kg/m2. Totte et al included 126 patients with an average starting body mass index of 37.7 kg/m2. (Gaur S. Gastrointest Endosc 2015)
ÀüÈÆÀç ±³¼ö´Ô comment: ¹Ì¿ë ¸ñÀûÀ¸·Î ½Ã¼úÇϱ⺸´Ù´Â BMI ±âÁØÀ» Á¤ÇÏ¿© obesity, metabolic diseaseÀÇ Ä¡·á ¸ñÀûÀ¸·Î ½Ã¼úÇÏ´Â °ÍÀÌ ¹Ù¶÷Á÷ÇÒ °ÍÀÔ´Ï´Ù. ÇâÈÄ bariatric endoscopy°¡ Áß¿äÇØ Áú °ÍÀ̸ç (1) balloon, (2) suture, (3) stent°¡ Áß¿äÇÑ ¹æ¹ýÀ¸·Î ÀÚ¸®ÀâÀ» °ÍÀÔ´Ï´Ù. ÇöÀç´Â Çй®ÀûÀÎ bias°¡ ½ÉÇÑ ÆíÀÌ°í, ´ëÇа¡¿¡¼´Â °ü½ÉÀÌ ¾ø´Âµ¥, ½Ã¼úºñ 400-500¸¸¿ø Á¤µµ·Î ÀϺΠÁö¿ª¿¡¼ ½ÃÇàµÇ°í ÀÖ´Ù°í ÇÕ´Ï´Ù. ¹æÇâÀ» ´Ù½Ã ÀâÀ» ÇÊ¿ä°¡ ÀÖ½À´Ï´Ù.
2) 2016-9-23 ³»½Ã°æÇÐȸ Áý´ãȸ The development of novel endoscopic bypass stent: in porcine animal model (°í·Á´ëÇб³ ÃÖº´°ü)
Endobarrier¿Í ºñ½ÁÇÏ°Ô ePTEF ÀçÁúÀ» »ç¿ëÇÑ »õ·Î¿î ºñ¸¸ Ä¡·á¿ë stent¸¦ ¸¸µé¾ú´Ù°í ÇÕ´Ï´Ù.
* ÀüÈÆÀç ±³¼ö´Ô comment: Endobarrier´Â FDA °øÀÎÀ» ¹Þ¾ÒÁö¸¸, ºñ½Î°í (1,000¸¸¿ø Á¤µµ), ºÎÀÛ¿ë (migration, pancreatitis, liver abscess)ÀÌ ¸¹½À´Ï´Ù. º¸´Ù È¿°úÀûÀÎ ºñ¸¸ stent¸¦ À§Çؼ´Â º¸´Ù À¯¿ëÇÑ suture machineÀÌ °³¹ßµÇ¾î¾ß ÇÒ °Í °°½À´Ï´Ù.
1) [2013-9-24. Á¶¼±ÀϺ¸] 70§¸ ÀÌ»ó °¨·®ÇÑ ÃÊ°íµµ ºñ¸¸Ò³ ¼ûÁøä ¹ß°ß
ÇѶ§ ¸ö¹«°Ô°¡ 130§¸ÀÌ ³Ñ´Â ÃÊ°íµµ ºñ¸¸³à¿´´Ù°¡ À§¹êµå ¼ö¼ú µîÀ¸·Î 70§¸ ÀÌ»óÀ» °¨·®Çß´ø 20´ë ¿©¼ºÀÌ ¼ûÁø ä ¹ß°ßµÆ´Ù. Áö³ 22ÀÏ ¿ÀÈÄ 11½Ã 20ºÐÂë ´ë±¸ ´Þ¼±¸ È£¸²µ¿ÀÇ ÇÑ ¸ðÅÚ ÈÀå½Ç¿¡¼ S(24)¾¾°¡ ¼ûÁ® ÀÖ´Â °ÍÀ» ³²ÀÚ Ä£±¸(23)°¡ ¹ß°ßÇß´Ù. ³²ÀÚ Ä£±¸´Â "¿©ÀÚ Ä£±¸ÀÇ »ýÀÏ ÆÄƼ¸¦ À§ÇØ ¸ðÅÚ¿¡ Åõ¼÷ÇÑ µÚ °í±â¸¦ ±¸¿ö ¸Ô´Â µî ½Ã°£À» º¸³»´Ù°¡ ÈÀå½Ç¿¡ ±¸Å並 ÇÏ·¯ °£´Ù°í Çؼ µÚµû¶ó °¬´õ´Ï ÀǽÄÀ» ÀÒ°í ¾²·¯Á® ÀÖ¾ú´Ù"°í ¸»Çß´Ù. ¼ûÁø S¾¾´Â Áö³ÇØ ÃÊ ÇÑ ÄÉÀ̺í¹æ¼Û¿¡¼ 130§¸ÀÌ ³Ñ´Â ÃÊ°íµµ ºñ¸¸³à·Î ¼Ò°³µÈ µÚ ¿ÃÇØ ÃÊ °¨·®À» À§ÇØ À§¹êµå ¼ö¼úÀ» ¹Þ¾ÒÀ¸¸ç, ÀÌ ¸ð½ÀÀÌ ¹æ¼Û ÇÁ·Î±×·¥¿¡ ¼Ò°³µÆ´Ù. À§¹êµå ¼ö¼úÀº À§ÀÇ ÀϺκп¡ ÀÇ·á¿ë ¹êµå¸¦ ÀåÂøÇØ À§ÀÇ Å©±â¸¦ ÁÙÀÌ´Â °ÍÀ¸·Î, ºñ¸¸ ȯÀڵ鿡°Ô ÀαⰡ ³ôÀº °ÍÀ¸·Î ¾Ë·ÁÁö°í ÀÖ´Ù.
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.